Trials / Recruiting
RecruitingNCT06700304
CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
CAN-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Neuralink Corp · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The CAN-PRIME Study is to test the safety and functionality of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs (tetraparesis or tetraplegia). The N1 Implant is a small, wireless device placed in the skull. It connects to tiny threads inserted into the brain by the R1 Robot, which is a machine designed to carefully place these threads. This study will help researchers learn how well the implant and robot work and if they are safe for use.
Conditions
- Tetraplegia/Tetraparesis
- Quadriplegia
- Quadriplegia/Tetraplegia
- Cervical Spinal Cord Injury
- Amyotrophic Lateral Sclerosis (ALS)
- Spinal Cord Injury (Quadraplegia)
- Spinal Cord Injury
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | N1 Implant | The N1 Implant is a type of implantable brain-computer interface. |
| DEVICE | R1 Robot | The R1 Robot is a robotic electrode thread inserter that implants the N1 Implant. |
Timeline
- Start date
- 2024-11-20
- Primary completion
- 2027-11-30
- Completion
- 2030-11-30
- First posted
- 2024-11-21
- Last updated
- 2025-05-31
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06700304. Inclusion in this directory is not an endorsement.